Get started
Author

Stéphanie Dehette

Observed names: DEHETTE, Stéphanie, Dehette Stéphanie, S Dehette, S. Dehette, Stephanie Dehette
OpenAlex ID: A5040358110
Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial
2015 · J.-L. Pujol, A. Lavole, et al. · Annals of Oncology · 99
Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
2022 · Didier Debieuvre, Olivier Molinier, et al. · The Lancet Regional Health - Europe · 85
PDF
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial
2022 · Virginie Westeel, Pascal Foucher, et al. · The Lancet Oncology · 70
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
2018 · Guy Meyer, Benjamin Besse, et al. · European Respiratory Journal · 55
PDF
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
2021 · Léo Plaçais, Jean-Marie Michot, et al. · Brain Communications · 49
PDF
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
2014 · Delphine Lerouge, Alain Rivière, et al. · BMC Cancer · 25
PDF
Relation entre cancer bronchique primitif et consommation tabagique. Résultats de l’étude KBP-2010-CPHG du Collège des pneumologues des hôpitaux généraux
2015 · D. Coëtmeur, G. Leveiller, et al. · Revue des Maladies Respiratoires · 6
106TiP PULSE, a non-inferiority study of maintenance pembrolizumab at usual or low dose in non-squamous lung cancer
2024 · J. Remon Masip, C. Helissey, et al. · ESMO Open · 5
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts
2024 · T.C.T. Hoang, D. Debieuvre, et al. · ESMO Open · 4
PDF
OA 16.03 Recurrences and 2nd Primary Cancers in the IFCT-0302 Trial Assessing a CT-Scan-Based Follow-Up after Lung Cancer Surgery
2017 · V. Westeel, F. Barlesi, et al. · Journal of Thoracic Oncology · 4
PDF
1538O Environmental pollutants and molecular alterations in non-small cell lung cancer: Insights from the KBP-2020 cohort study
2024 · A.B. Cortot, M. Genin, et al. · Annals of Oncology · 2
PDF
Nouvelle classification internationale TNM (7e édition) du cancer pulmonaire : explications et implications pratiques
2008 · A. Scherpereel, S. Dehette · Revue des Maladies Respiratoires · 2
Neurological Complications Induced by Anti-PD-1 or Anti-PD-L1: Prevalence, Clinical Description and Treatment: 5-Years Experience of a National Network
2019 · Léo Plaçais, Jean-Marie Michot, et al. · SSRN Electronic Journal · 1
Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution
2026 · Romain Corre, Isabelle Monnet, et al. · European Journal of Cancer
Cannabis smokers among lung cancer patients: data from real-life French study
2022 · O Molinier, D Templement, et al. · European Respiratory Journal
Effet anti-tumoral d’une héparine de bas poids moléculaire dans le cancer bronchique localisé : l’essai Tinzaparin In Lung Tumors (TILT)
2018 · P. Girard, B. Besse, et al. · Revue des Maladies Respiratoires
P1.01-039 Does Distance between Chest and Surgery Departments Impact Outcome in Lung Cancer Patients? Results of KBP-2010-CPHG Study
2017 · Didier Debieuvre, Violaine Frappat, et al. · Journal of Thoracic Oncology
PDF
Study KBP-2010-CPHG: Characteristics and management of 968 new cases of small-cell lung cancer (SCLC).
2013 · Charles Dayen, Daniel Coëtmeur, et al. · Journal of Clinical Oncology
Intérêt du dosage du marqueur Cyfra 21.1 dans le carcinome à petites cellules. Étude retrospective multicentrique sur 195 cas
2008 · Seth Malinowski, Claire Andréjak, et al.
Works count: 20
Citation count: 407
H-index: 6
I10-index: 6
Year
Topic
Type